An Integrated Genomic Analysis of Human Glioblastoma Multiforme

Cited by (1,034)

Items 101–200 of 1,034

1. Glutaminolysis: A Hallmark of Cancer Metabolism
   Yang, Lifeng, Venneti, Sriram, Nagrath, Deepak · 2017 · Annual Review of Biomedical Engineering
2. Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us?
   DeBerardinis, Ralph J., Thompson, Craig B. · 2012 · Cell
3. Metabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche
   Suda, Toshio, Takubo, Keiyo, Semenza, Gregg L. · 2011 · Cell Stem Cell
4. c-Myc and Cancer Metabolism
   Donald Max Miller, Shelia D. Thomas, Ashraful Islam, David E. Muench, Kara C. Sedoris · 2012 · Clinical Cancer Research
5. 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas
   Choi, Changho, Ganji, Sandeep K, DeBerardinis, Ralph J, Hatanpaa, Kimmo J, Rakheja, Dinesh, Kovacs, Zoltan, Yang, Xiao-Li, Mashimo, Tomoyuki, Raisanen, Jack M, Marin-Valencia, Isaac et al. · 2012 · Nature Medicine
6. Metabolomics and Isotope Tracing
   Cholsoon Jang, Li Chen, Joshua D. Rabinowitz · 2018 · Cell
7. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
   Bin‐Bing S. Zhou, Haiying Zhang, Marc Isaac Damelin, Kenneth G. Geles, Justin C. Grindley, Peter B. Dirks · 2009 · Nature Reviews Drug Discovery
8. Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
   Jinghui Zhang, Gang Wu, Matthew D. Parker, Robert Huether, Xiang 'Anthony' Chen, Erin Hedlund, Panduka Nagahawatte, Michael Rusch, Jared B. Becksfort, Yongjin Li et al. · 2013 · Nature Genetics
9. Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
   Jones, Siân, Hruban, Ralph H., Kamiyama, Mihoko, Borges, Michael, Zhang, Xiaosong, Parsons, D. Williams, Lin, Jimmy Cheng-Ho, Palmisano, Emily, Brune, Kieran, Jaffee, Elizabeth M. et al. · 2009 · Science
10. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas
    Christian Johannes Hartmann, Bettina Hentschel, Wolfgang Wick, David Capper, Jörg Felsberg, Matthias Simon, Manfred Westphal, Gabriele Schackert, Richard Meyermann, Torsten Pietsch et al. · 2010 · Acta Neuropathologica
11. Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?
    Dominico Vigil, Jacqueline Cherfils, Kent L. Rossman, Channing J. Der · 2010 · Nature reviews. Cancer
12. Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
    Mellinghoff, Ingo K., van den Bent, Martin J., Blumenthal, Deborah T., Touat, Mehdi, Peters, Katherine B., Clarke, Jennifer, Mendez, Joe, Yust-Katz, Shlomit, Welsh, Liam, Mason, Warren P. et al. · 2023 · New England Journal of Medicine
13. Molecular networks as sensors and drivers of common human diseases
    Eric E. Schadt · 2009 · Nature
14. NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
    Wolfgang Wick, Christian Johannes Hartmann, Corinna Engel, Mandy Stoffels, Jörg Felsberg, Florian Stockhammer, Michael Sabel, Susanne Koeppen, Ralf Ketter, Richard Meyermann et al. · 2009 · Journal of Clinical Oncology
15. IDH1andIDH2Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia WithNPM1Mutation WithoutFLT3Internal Tandem Duplication
    Peter Paschka, Richard F. Schlenk, Verena I. Gaidzik, Marianne Habdank, Jan Krönke, Lars Bullinger, Daniela Späth, Sabine Käyser, Manuela Zucknick, Katharina S. S. Götze et al. · 2010 · Journal of Clinical Oncology
16. WHO 2016 Classification of gliomas
    Pieter Wesseling, David Capper · 2017 · Neuropathology and Applied Neurobiology
17. Adult Glioblastoma
    Brian Michael Alexander, Timothy Francis Cloughesy · 2017 · Journal of Clinical Oncology
18. Metabolic reprogramming and epigenetic modifications on the path to cancer
    Linchong Sun, Huafeng Zhang, Ping Gao · 2021 · Protein & Cell
19. Accumulation of driver and passenger mutations during tumor progression
    Ivana Božić, Tibor Antal A, Hisashi Ohtsuki, Hannah K. Carter, Dewey Kim, Sining Chen, Rachel Karchin, Kenneth W. Kinzler, Bert Vogelstein, Martin A. Nowak · 2010 · Proceedings of the National Academy of Sciences
20. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme
    Wolf, Amparo, Agnihotri, Sameer, Micallef, Johann, Mukherjee, Joydeep, Sabha, Nesrin, Cairns, Rob, Hawkins, Cynthia, Guha, Abhijit · 2011 · Journal of Experimental Medicine
21. Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
    Ahmed A. Ahmed, Dariush Etemadmoghadam, Jillian Temple, Andy G. Lynch, Mohamed Riad, Raghwa N. Sharma, Colin J.R. Stewart, Sián Fereday, Carlos Caldas, Anna DeFazio et al. · 2010 · The Journal of Pathology
22. Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM
    Vaske, Charles J., Benz, Stephen C., Sanborn, J. Zachary, Earl, Dent, Szeto, Christopher, Zhu, Jingchun, Haussler, David, Stuart, Joshua M. · 2010 · Bioinformatics
23. Genome-wide association study identifies five susceptibility loci for glioma
    Sanjay S. Shete, Fay J. Hosking, Lindsay B. Robertson, Sara E. Dobbins, Marc Sanson, Beatrice Malmer, Matthias Simon, Yannick Marie, Blandine Boisselier, Jean‐Yves Delattre et al. · 2009 · Nature Genetics
24. Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary
    Sohrab P. Shah, Martin Köbel, Janine Senz, Ryan D. Morin, Blaise Alexander Clarke, Kimberly C. Wiegand, Gillian Leung, Abdalnasser Zayed, Erika Mehl, Steve E. Kalloger et al. · 2009 · New England Journal of Medicine
25. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma
    Jason T. Huse, Eric C. Holland · 2010 · Nature reviews. Cancer
26. IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
    Guido Marcucci, Kati S. Maharry, Yue-Zhong Wu, Michael D. Radmacher, Krzysztof Mrózek, Dean Margeson, Kelsi B. Holland, Susan P. Whitman, Heiko Becker, Sebastian Schwind et al. · 2010 · Journal of Clinical Oncology
27. RAS Interaction with PI3K: More Than Just Another Effector Pathway
    Castellano, E., Downward, J. · 2011 · Genes & Cancer
28. Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
    Walter Taal, Hendrika M. Oosterkamp, Annemiek Walenkamp, Hendrikus Jan Dubbink, Laurens Victor Beerepoot, Monique C.J. Hanse, Jan Buter, Aafke H. Honkoop, Dolf H. Boerman, Filip De Vos et al. · 2014 · The Lancet Oncology
29. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy
    Huilin Shao, Jaehoon Chung, Leonora Balaj, Alain Charest, Darell D. Bigner, Bob S. Carter, Fred H. Hochberg, Xandra O. Breakefield, Ralph Weissleder, Hakho Lee · 2012 · Nature Medicine
30. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations
    Gross, Stefan, Cairns, Rob A., Minden, Mark D., Driggers, Edward M., Bittinger, Mark A., Jang, Hyun Gyung, Sasaki, Masato, Jin, Shengfang, Schenkein, David P., Su, Shinsan M. et al. · 2010 · Journal of Experimental Medicine
31. miR-34 – a microRNA replacement therapy is headed to the clinic
    Andreas G. Bader · 2012 · Frontiers in Genetics
32. Frequent Mutation of Isocitrate Dehydrogenase(IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
    Borger, Darrell R., Tanabe, Kenneth K., Fan, Kenneth C., Lopez, Hector U., Fantin, Valeria R., Straley, Kimberly S., Schenkein, David P., Hezel, Aram F., Ancukiewicz, Marek, Liebman, Hannah M. et al. · 2012 · The Oncologist
33. Glioma targeted therapy: insight into future of molecular approaches
    Keyang Yang, Zhijing Wu, Hao Zhang, Nan Zhang, Wantao Wu, Zeyu Wang, Ziyu Dai, Xun Zhang, Liyang Zhang, Yun Peng et al. · 2022 · Molecular Cancer
34. The Genetic Landscape of the Childhood Cancer Medulloblastoma
    Donald Williams Parsons, Meng Li, Xiaosong Zhang, Siân Jones, Rebecca J. Leary, Jimmy Lin, Simina Maria Boca, Hannah K. Carter, Josue A. Samayoa, Chetan Bettegowda et al. · 2010 · Science
35. Genetic and molecular epidemiology of adult diffuse glioma
    Annette M. Molinaro, Jennie Webster Taylor, John K. Wiencke, Margaret Wrensch · 2019 · Nature Reviews Neurology
36. A vaccine targeting mutant IDH1 induces antitumour immunity
    Theresa Schumacher, Lukas Bunse, Stefan Pusch, Felix Sahm, Benedikt Wiestler, Jasmin Quandt, Oliver Menn, Matthias Osswald, Iris Oezen, Martina Ott et al. · 2014 · Nature
37. IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
    Sumihito Nobusawa, Takuya Watanabe, Paul Kleihues, Hiroko Ohgaki · 2009 · Clinical Cancer Research
38. Ras history: The saga continues
    Cox, Adrienne D., Der, Channing J. · 2010 · Small GTPases
39. Glioblastoma: pathology, molecular mechanisms and markers
    Aldape, Kenneth, Zadeh, Gelareh, Mansouri, Sheila, Reifenberger, Guido, von Deimling, Andreas · 2015 · Acta Neuropathologica
40. The interplay between cell signalling and the mevalonate pathway in cancer
    Peter Mullen, Rosemary Yu, Joseph Longo, Michael C. Archer, Linda Z. Penn · 2016 · Nature reviews. Cancer
41. A human functional protein interaction network and its application to cancer data analysis
    Wu, Guanming, Feng, Xin, Stein, Lincoln · 2010 · Genome Biology
42. An Extensive MicroRNA-Mediated Network of RNA-RNA Interactions Regulates Established Oncogenic Pathways in Glioblastoma
    Pavel Sumazin, Xuerui Yang, Hua‐Sheng Chiu, Wei‐Jen Chung, Archana P. Iyer, David Llobet‐Navàs, Presha Rajbhandari, Mukesh Bansal, Paolo Guarnieri, José Silva et al. · 2011 · Cell
43. Mosaic Analysis with Double Markers Reveals Tumor Cell of Origin in Glioma
    Chong Liu, Jonathan C. Sage, Michael Ryan Miller, Roel G.W. Verhaak, Simon Hippenmeyer, Hannes S. Vogel, Oded Foreman, Roderick Terry Bronson, Akiko Nishiyama, Liqun Luo et al. · 2011 · Cell
44. Exploring the Genomes of Cancer Cells: Progress and Promise
    Michael R. Stratton · 2011 · Science
45. Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research
    Kurhanewicz, John, Vigneron, Daniel B., Brindle, Kevin, Chekmenev, Eduard Y., Comment, Arnaud, Cunningham, Charles H., DeBerardinis, Ralph J., Green, Gary G., Leach, Martin O., Rajan, Sunder S. et al. · 2011 · Neoplasia
46. Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
    Jason F. Wiggins, Lynnsie Ruffino, Kevin Kelnar, Michael Omotola, Lubna Patrawala, David Brown, Andreas G. Bader · 2010 · Cancer Research
47. Survival in glioblastoma: a review on the impact of treatment modalities
    Pedro David Delgado López, Eva María Corrales-García · 2016 · Clinical & Translational Oncology
48. Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology
    Lonneke A.M. Gravendeel, Mathilde C.M. Kouwenhoven, Olivier Gevaert, Johan J. de Rooi, Andrew Stubbs, J. Elza Duijm, Anneleen Daemen, Fonnet E. Bleeker, Linda B.C. Bralten, Nanne K. Kloosterhof et al. · 2009 · Cancer Research
49. Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation
    Hao Wu, Yi Zhang · 2011 · Genes & Development
50. Advances in the molecular genetics of gliomas — implications for classification and therapy
    Reifenberger, Guido, Wirsching, Hans-Georg, Knobbe-Thomsen, Christiane B., Weller, Michael · 2017 · Nature Reviews Clinical Oncology
51. Medulloblastomics: the end of the beginning
    Paul A. Northcott, David Jones, Marcel Kool, Giles W Robinson, Richard J. Gilbertson, Yoon‐Jae Cho, Scott L. Pomeroy, Andrey Korshunov, Peter Lichter, Michael D. Taylor et al. · 2012 · Nature reviews. Cancer
52. Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis
    Zhang, Wen Cai, Shyh-Chang, Ng, Yang, He, Rai, Amit, Umashankar, Shivshankar, Ma, Siming, Soh, Boon Seng, Sun, Li Li, Tai, Bee Choo, Nga, Min En et al. · 2012 · Cell
53. Cancer as a metabolic disease
    Thomas N. Seyfried, Laura M. Shelton · 2010 · Nutrition & Metabolism
54. Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine
    Zhang, Ji, Pavlova, Natalya N, Thompson, Craig B · 2017 · The EMBO Journal
55. Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease
    Barbara S. Paugh, Chunxu Qu, Chris Jones, Zhaoli Liu, Martyna Adamowicz‐Brice, Junyuan Zhang, Dorine A. Bax, Beth Coyle, Jennifer Barrow, Darren R. Hargrave et al. · 2010 · Journal of Clinical Oncology
56. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
    Priscilla Kaliopi Brastianos, Peleg Moshe Horowitz, Sandro Santagata, Robert T. Jones, Aaron McKenna, Gad A. Getz, Keith Lloyd Ligon, Emanuele Palescandolo, Paul Van Hummelen, Matthew D. Ducar et al. · 2013 · Nature Genetics
57. T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
    Karolina I. Woroniecka, Pakawat Chongsathidkiet, Kristen Elizabeth Rhodin, Hanna R. Kemeny, Cosette A. Dechant, Samuel Harrison Farber, Aladine A. Elsamadicy, Xiuyu Cui, Shohei Koyama, Christina Jackson et al. · 2018 · Clinical Cancer Research
58. Transcription factors as readers and effectors of DNA methylation
    Zhu, Heng, Wang, Guohua, Qian, Jiang · 2016 · Nature Reviews Genetics
59. Glioma
    Michael Weller, Patrick Yung Wen, Susan Marina Chang, Linda Dirven, Michael K. Lim, Michelle Monje, Guido Reifenberger · 2024 · Nature Reviews Disease Primers
60. Cancer genomics: from discovery science to personalized medicine
    Lynda Chin, Jannik N. Andersen, P. Andrew Futreal · 2011 · Nature Medicine
61. International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data
    Jian Zhang, Joachim Baran, A. Cros, Jonathan M. Guberman, Syed Aleem Haider, Jocelyn C. Hsu, Yong Liang, Elena Rivkin, J. Wang, Brett R. Whitty et al. · 2011 · Database
62. IDH1 and IDH2 mutations in gliomas
    Cohen, Adam L., Holmen, Sheri L., Colman, Howard · 2013 · Current Neurology and Neuroscience Reports
63. Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid
    Alexandra Michelle Miller, Ronak H. Shah, Elena I. Pentsova, Maryam Pourmaleki, Samuel R. Briggs, Natalie M. DiStefano, Youyun Zheng, Anna Skakodub, Smrutiben A. Mehta, Carl Campos et al. · 2019 · Nature
64. Acute myeloid leukaemia
    Asim Khwaja, Magnus Björkholm, Rosemary E. Gale, Ross L. Levine, Craig T. Jordan, Gerhard Ehninger, Clara Derber Bloomfield, Elihu H. Estey, Alan K. Burnett, Jan J. Cornelissen et al. · 2016 · Nature Reviews Disease Primers
65. Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network
    Michael Weller, Jörg Felsberg, Christian Johannes Hartmann, Hilmar Berger, Joachim Peter Steinbach, Johannes Schramm, Manfred Westphal, Gabriele Schackert, Matthias Simon, Jörg Christian Tonn et al. · 2009 · Journal of Clinical Oncology
66. CGCG clinical practice guidelines for the management of adult diffuse gliomas
    Tao Jiang, Ying Qing Mao, Wenbin Ma, Qing Mao, Yongping You, Xuejun Yang, Chuanlu Jiang, Chunsheng Kang, Xuejun Li, Ling Chen et al. · 2016 · Cancer Letters
67. Mechanisms of Chromosomal Instability
    Sarah L. Thompson, Samuel F. W. Bakhoum, Duane A. Compton · 2010 · Current Biology
68. IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas
    Koichi Ichimura, Danita M. Pearson, Sylvia Kocialkowski, L. Magnus Bäcklund, Raymond Chan, David Jones, Vincent Peter Collins · 2009 · Neuro-Oncology
69. Therapeutic opportunities within the DNA damage response
    Pearl, Laurence H., Schierz, Amanda C., Ward, Simon E., Al-Lazikani, Bissan, Pearl, Frances M. G. · 2015 · Nature Reviews Cancer
70. Frequent ATRX , CIC , FUBP1 and IDH1 mutations refine the classification of malignant gliomas
    Yuchen Jiao, Patrick J. Killela, Zachary J. Reitman, B. Ahmed Rasheed, Christopher M. Heaphy, Roeland F. de Wilde, Fausto J. Rodríguez, Sérgio Rosemberg, Sueli Mieko Oba‐Shinjo, Suely Kazue Nagahashi Marie et al. · 2012 · Oncotarget
71. Current and future strategies for treatment of glioma
    Nancy Ann Oberheim Bush, Susan Marina Chang, Mitchel Stuart Berger · 2016 · Neurosurgical Review
72. Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia
    Steven M. Chan, Danièl Thomas, M. Ryan Corces, Seethu Xavy, Suchita Rastogi, Wan‐Jen Hong, Feifei Zhao, Bruno C. Medeiros, David A. Tyvoll, Ravindra Majeti · 2015 · Nature Medicine
73. The Spectrum of SWI/SNF Mutations, Ubiquitous in Human Cancers
    Alan Hunter Shain, Jonathan R. Pollack · 2013 · PLoS ONE
74. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation
    Hui Yang, Yi Liu, F Bai, Jy Zhang, S-H Ma, J Liu, Z-D Xu, H-G Zhu, Z-Q Ling, Dingwei Ye et al. · 2012 · Oncogene
75. Multidimensional communication in the microenvirons of glioblastoma
    Marike L. D. Broekman, Sybren L. N. Maas, Erik R. Abels, Thorsten R. Mempel, Anna M. Krichevsky, Xandra O. Breakefield · 2018 · Nature Reviews Neurology
76. Microfluidic isolation and transcriptome analysis of serum microvesicles
    Chen, Chihchen, Skog, Johan, Hsu, Chia-Hsien, Lessard, Ryan T., Balaj, Leonora, Wurdinger, Thomas, Carter, Bob S., Breakefield, Xandra O., Toner, Mehmet, Irimia, Daniel · 2010 · Lab Chip
77. Methionine metabolism in health and cancer: a nexus of diet and precision medicine
    Sydney M. Sanderson, Xia Gao, Ziwei Dai, Jason W. Locasale · 2019 · Nature reviews. Cancer
78. What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
    Losman, Julie-Aurore, Kaelin, William G. · 2013 · Genes & Development
79. Regulation of the pentose phosphate pathway in cancer
    Peng Jiang, Wenjing Du, Mian Wu · 2014 · Protein & Cell
80. Applications of New Sequencing Technologies for Transcriptome Analysis
    Olena Morozova, Martin Hirst, Marco A. Marra · 2009 · Annual Review of Genomics and Human Genetics
81. Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism
    Reitman, Z. J., Yan, H. · 2010 · JNCI Journal of the National Cancer Institute
82. Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome
    Pansuriya, Twinkal C, van Eijk, Ronald, d'Adamo, Pio, van Ruler, Maayke A J H, Kuijjer, Marieke L, Oosting, Jan, Cleton-Jansen, Anne-Marie, van Oosterwijk, Jolieke G, Verbeke, Sofie L J, Meijer, Daniëlle et al. · 2011 · Nature Genetics
83. Emerging insights into the molecular and cellular basis of glioblastoma
    Gavin P. Dunn, Mikael L. Rinne, Jill Wykosky, Giannicola Genovese, Steven N. Quayle, Ian F. Dunn, Pankaj Kumar Agarwalla, Milan G. Chheda, Benito Campos, Alan Wang et al. · 2012 · Genes & Development
84. The emerging role and targetability of the TCA cycle in cancer metabolism
    Nicole M. Anderson, Patrick Mucka, Joseph G. Kern, Hui Feng · 2017 · Protein & Cell
85. Cancer attractors: A systems view of tumors from a gene network dynamics and developmental perspective
    Sui Huang, Ingemar T. Ernberg, Stuart Alan Kauffman · 2009 · Seminars in Cell and Developmental Biology
86. 2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity
    Parker L. Sulkowski, Christopher D. Corso, Nathaniel D. Robinson, Susan E. Scanlon, Karin R. Purshouse, Hanwen Bai, Yanfeng Liu, Ranjini K. Sundaram, Denise Campisi Hegan, Nathan R. Fons et al. · 2017 · Science Translational Medicine
87. Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge
    Sturm, Dominik, Bender, Sebastian, Jones, David T. W., Lichter, Peter, Grill, Jacques, Becher, Oren, Hawkins, Cynthia, Majewski, Jacek, Jones, Chris, Costello, Joseph F. et al. · 2014 · Nature Reviews Cancer
88. Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma
    Chetan Bettegowda, Nishant Agrawal, Yuchen Jiao, Mark Sausen, Laura DeLong Wood, Ralph H. Hruban, Fausto J. Rodríguez, Daniel P. Cahill, Roger E. McLendon, Gregory Joseph Riggins et al. · 2011 · Science
89. PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
    Xiaoman Li, Changjing Wu, Nianci Chen, Huadi Gu, Allen Yen, Liu Cao, Enhua Wang, Liang Wang · 2016 · Oncotarget
90. Glioblastoma multiforme: a review of where we have been and where we are going
    Cory Adamson, Okezie Obasi Kanu, Ankit Indravadan Mehta, Chunhui Di, Ningjing Lin, Austin K. Mattox, Darell D. Bigner · 2009 · Expert Opinion on Investigational Drugs
91. The integrated landscape of driver genomic alterations in glioblastoma
    Frattini, Veronique, Trifonov, Vladimir, Chan, Joseph Minhow, Castano, Angelica, Lia, Marie, Abate, Francesco, Keir, Stephen T, Ji, Alan X, Zoppoli, Pietro, Niola, Francesco et al. · 2013 · Nature Genetics
92. Declining childhood and adolescent cancer mortality
    Smith, Malcolm A., Altekruse, Sean F., Adamson, Peter C., Reaman, Gregory H., Seibel, Nita L. · 2014 · Cancer
93. First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
    Linda M. Liau, Keyoumars Ashkan, David Dinh Tran, Jian Li Campian, John E. Trusheim, Charles Cobbs, Jason Heth, Michael E. Salacz, Sarah A. Taylor, Stacy D. D’Andre et al. · 2018 · Journal of Translational Medicine
94. Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells
    Claudia Scholl, Stefan Fröhling, Ian F. Dunn, Anna C. Schinzel, David Allen Barbie, So Young Kim, Serena J. Silver, Pablo Tamayo, Raymond Couric Wadlow, Sridhar Ramaswamy et al. · 2009 · Cell
95. Fibroblast growth factors and their receptors in cancer
    Jørgen Wesche, Kaisa Haglund, Ellen Margrethe Haugsten · 2011 · Biochemical Journal
96. Glioblastoma Subclasses Can Be Defined by Activity among Signal Transduction Pathways and Associated Genomic Alterations
    Cameron Brennan, Hiroyuki Momota, Dolores Hambardzumyan, Tatsuya Ozawa, Adesh Tandon, Alicia M. Pedraza, Eric C. Holland · 2009 · PLoS ONE
97. Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
    Ayalew Tefferi · 2010 · Leukemia
98. IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
    Caroline Houillier, X. Wang, Gentian Kaloshi, Karima Mokhtari, Rémy Guillevin, Julien Laffaire, Sophie Paris, Blandine Boisselier, Ahmed Idbaïh, Florence Laigle–Donadey et al. · 2010 · Neurology
99. TERT PROMOTER MUTATIONS OCCUR FREQUENTLY IN GLIOMAS AND A SUBSET OF TUMORS DERIVED FROM CELLS WITH LOW RATES OF SELF-RENEWAL
    Hai Yan, Patrick J. Killela, Zachary J. Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, L. A. Diaz, Allan H. Friedman, Henry S. Friedman, Gary L. Gallia et al. · 2014 · Neuro-Oncology
100. EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt
     Hui Miao, Da‐Qiang Li, Amitava Mukherjee, Hong Guo, Aaron P. Petty, Jennifer L. Cutter, James P. Basilion, John R. Sedor, Jiong Wu, David Danielpour et al. · 2009 · Cancer Cell